HRS-8080 / Jiangsu Hengrui Pharma 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HRS-8080 / Jiangsu Hengrui Pharma
NCT06167694: Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

Recruiting
1/2
146
RoW
HRS-8080; Dalpiciclib Isethionate Tablets
Shandong Suncadia Medicine Co., Ltd.
Unresectable or Metastatic Breast Cancer
10/25
12/25
NCT06222879: Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Recruiting
1/2
350
RoW
HRS-8080; SHR-A1811, HRS-8080; SHR-A2009, SHR-A2009; SHR-1316
Shandong Suncadia Medicine Co., Ltd.
Breast Cancer
10/26
10/26
NCT06555068: A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients

Recruiting
1/2
528
RoW
HRS-6209 in Combination with Fulvestrant, HRS-6209 in Combination with HRS-1358, HRS-6209 in Combination with Letrozole, HRS-6209 in Combination with HRS-8080
Jiangsu HengRui Medicine Co., Ltd.
Advanced Unresectable or Metastatic Breast Cancer
12/25
08/26
NCT06679036: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Recruiting
1/2
300
RoW
HRS-2189, Fluvustat, HRS-8080, HRS-6209, HRS-1358
Shandong Suncadia Medicine Co., Ltd.
Advanced Unresectable or Metastatic Breast Cancer
10/26
12/26
HRS-8080-102, NCT06619873: A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

Not yet recruiting
1
24
RoW
HRS-8080
Shandong Suncadia Medicine Co., Ltd.
Breast Cancer
10/24
11/24
NCT05189717: A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults

Enrolling by invitation
1
156
RoW
HRS-8080 tablets、SHR 6390 tablets、Abemaciclib、Everolimus
Shandong Suncadia Medicine Co., Ltd.
Metastatic or Local Advanced Breast Cancer of Patients
10/24
07/25
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HRS-8080 / Jiangsu Hengrui Pharma
NCT06167694: Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer

Recruiting
1/2
146
RoW
HRS-8080; Dalpiciclib Isethionate Tablets
Shandong Suncadia Medicine Co., Ltd.
Unresectable or Metastatic Breast Cancer
10/25
12/25
NCT06222879: Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer

Recruiting
1/2
350
RoW
HRS-8080; SHR-A1811, HRS-8080; SHR-A2009, SHR-A2009; SHR-1316
Shandong Suncadia Medicine Co., Ltd.
Breast Cancer
10/26
10/26
NCT06555068: A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patients

Recruiting
1/2
528
RoW
HRS-6209 in Combination with Fulvestrant, HRS-6209 in Combination with HRS-1358, HRS-6209 in Combination with Letrozole, HRS-6209 in Combination with HRS-8080
Jiangsu HengRui Medicine Co., Ltd.
Advanced Unresectable or Metastatic Breast Cancer
12/25
08/26
NCT06679036: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients

Recruiting
1/2
300
RoW
HRS-2189, Fluvustat, HRS-8080, HRS-6209, HRS-1358
Shandong Suncadia Medicine Co., Ltd.
Advanced Unresectable or Metastatic Breast Cancer
10/26
12/26
HRS-8080-102, NCT06619873: A Phase 1, Randomized, Crossover Study to Evaluate the Relative Bioavailability and Food Effect of HRS-8080 in Healthy Subjects

Not yet recruiting
1
24
RoW
HRS-8080
Shandong Suncadia Medicine Co., Ltd.
Breast Cancer
10/24
11/24
NCT05189717: A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults

Enrolling by invitation
1
156
RoW
HRS-8080 tablets、SHR 6390 tablets、Abemaciclib、Everolimus
Shandong Suncadia Medicine Co., Ltd.
Metastatic or Local Advanced Breast Cancer of Patients
10/24
07/25

Download Options